In Sweden, the age-standardized incidence rate of low-risk prostate cancer, a marker of diagnostic activity in general and PSA testing in particular, was lower in men with low household income compared with high household income and in those born in a non-Nordic country compared with Nordic-born men. The gene discussed is KLK3; the disease is prostate carcinoma.